AIDX - 20/20 Biolabs, Inc.
1.8
0.070 3.889%
Share volume: 296,102
Last Updated: 03-27-2026
Business Services/Services – Research, Development, Testing Labs:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$1.73
0.07
0.04%
Fundamental analysis
0%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
0%
Performance
5 Days
9.76%
1 Month
-46.90%
3 Months
-92.45%
6 Months
-92.45%
1 Year
-92.45%
2 Year
-92.45%
Key data
Stock price
$1.80
DAY RANGE
$1.68 - $1.84
52 WEEK RANGE
$1.51 - $50.00
52 WEEK CHANGE
-$92.45
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Jonathan Cohen
Region: US
Website: 2020biolabs.com
Employees: 14
IPO year: 2026
Issue type:
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services
Region: US
Website: 2020biolabs.com
Employees: 14
IPO year: 2026
Issue type:
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services
We develop and commercialize AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. Our principal executive offices are located in Gaithersburg, MD.
Recent news